Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
2.360
-0.070 (-2.88%)
Feb 21, 2025, 4:00 PM EST - Market closed

Tango Therapeutics Stock Forecast

TNGX's stock price has decreased by -79.88% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Tango Therapeutics stock have an average target of 13.14, with a low estimate of 8.00 and a high estimate of 19. The average target predicts an increase of 456.78% from the current stock price of 2.36.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $8.00 $13.14 $13 $19
Change +238.98% +456.78% +450.85% +705.08%
* Price targets were last updated on Nov 11, 2024.

Analyst Ratings

The average analyst rating for Tango Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Sep '24Oct '24Nov '24Dec '24Jan '25Feb '25
Strong Buy 444444
Buy 444444
Hold 000000
Sell 000000
Strong Sell 000000
Total 888888

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Dec 5, 2024
B. Riley Securities
B. Riley Securities
Strong Buy
Maintains
$16$8
Strong Buy Maintains $16$8 +238.98% Nov 11, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$13
Strong Buy Reiterates $13 +450.85% Nov 8, 2024
Guggenheim
Guggenheim
Strong Buy
Maintains
$18$8
Strong Buy Maintains $18$8 +238.98% Nov 7, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$13
Strong Buy Reiterates $13 +450.85% Oct 28, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
46.66M
from 36.53M
Increased by 27.73%
Revenue Next Year
28.97M
from 46.66M
Decreased by -37.90%
EPS This Year
-1.22
from -1.08
EPS Next Year
-1.45
from -1.22
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
24.65M7.66M37.04M24.86M36.53M46.66M28.97M25.50M
Revenue Growth
--68.94%383.83%-32.89%46.93%27.73%-37.90%-11.99%
EPS
-1.57-1.63-0.94-1.23-1.08-1.22-1.45-1.49
EPS Growth
--------
Forward PE
--------
No. Analysts -----121210
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 56.3M 45.6M 45.6M
Avg 46.7M 29.0M 25.5M
Low 42.1M 19.6M n/a

Revenue Growth

Revenue Growth 202420252026202720282029
High
54.1%
-2.2%
57.5%
Avg
27.7%
-37.9%
-12.0%
Low
15.2%
-58.0%
-

EPS Forecast

EPS 202420252026202720282029
High -1.17 -1.27 -1.28
Avg -1.22 -1.45 -1.49
Low -1.23 -1.51 -1.59

EPS Growth

EPS Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.